[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioValues Avatar @BioValues BioValues

BioValues posts on X about $bcab, $incy, $exel, $mrsn the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXXX% stocks XXXXX% cryptocurrencies XXXX% exchanges XXXX%

Social topic influence $bcab #1, $incy #1, $exel #1, $mrsn 3.45%, bode 3.45%, dawn 3.45%, $dawn 3.45%, i know 3.45%, ton 3.45%, $prax XXXX%

Top accounts mentioned or mentioned by @investorclimber @aaronrosenblum5 @thebravecaptain @streetcred2017 @stmkrs @peterpaone @richardtip17589 @jul05310473john @polycle @lucy3370 @shitcosavant @peter_paone

Top assets mentioned Incyte Corporation (INCY) Exelixis Inc (EXEL) Dawn Protocol (DAWN) Praxis Precision Medicines, Inc. Common Stock (PRAX) Celldex Therapeutics, Inc (CLDX)

Top Social Posts

Top posts by engagements in the last XX hours

"$BCAB - $MRSN ADC buyout by $DAWN continues to bode well for BCAB's own deal prospects in a booming biotech market. Guidance is for a deal before end of year. Ironically BCAB also has its own preclinical B7-H7 asset. Will look for any hints at today's CC"
X Link 2025-11-13T13:30Z 8880 followers, 2087 engagements

"$BCAB I know a ton of skeptics on their guidance of a deal getting done before end of year (2 weeks left) but this is the kind of biotech market where deals get done vs XBI at XX. Going to be an eventful next week or so"
X Link 2025-12-04T16:04Z 8881 followers, 1743 engagements

"If only I had held X years $prax:"
X Link 2025-12-04T21:44Z 8880 followers, 7597 engagements

"$BCAB - $INCY I will say I took a listen to their investor presentations this week and they said business development for oncology will be part of their strategy. So GROK very well could be right here"
X Link 2025-12-05T16:01Z 8881 followers, 1336 engagements

"$BCAB if it's $EXEL the deal should be announced early next week ahead of their Wed R/D day. If nothing then $INCY likely top contender at any second before Dec 19"
X Link 2025-12-05T16:08Z 8888 followers, 1566 engagements

"$BCAB two more deals announced this morning (private bios with Novartis/Pfizer). Now in the final stretch for deals to be announced before Xmas week/EOY. So gives $BCAB X trading days to issue PR. If not $EXEL tomorrow then $INCY #1 pick for next week"
X Link 2025-12-09T15:10Z 8888 followers, 2430 engagements

"@thebravecaptain that's why R/S deadline in proxy is June XX vs. Nasdaq deadline of Feb X. It's insurance for down the line after deal is announced"
X Link 2025-12-10T16:46Z 8888 followers, XX engagements

"$JSPR so essentially the January bar to beat is $CLDX data. Equal or better efficacy to $CLDX with a BETTER safety profile"
X Link 2025-12-03T20:16Z 8884 followers, XXX engagements

"$BCAB obviously a lot of different potential partners out there (big or mid-cap) but maybe just maybe (ChatGPT's prediction for mid-cap) $EXEL:"
X Link 2025-12-04T16:09Z 8888 followers, 1352 engagements

"$BCAB should know who the partner is within X weeks of today. Been chatting with GROK and it seems convinced that EXEL (ChatGTP #1) or INCY (its #1) are the top contenders based on the HPV+ focus (see below). $INCY has been very vocal on doing deals and just did one with $PRLD"
X Link 2025-12-05T15:58Z 8888 followers, 2743 engagements

"$HOWL trading like we might get the big data update tomorrow. Super beat up from tax selling (was over $X recently) so significant upside if they can present a compelling data case/FDA update"
X Link 2025-12-10T18:44Z 8888 followers, XXX engagements